US Patent Issued to TECHNODERMA MEDICINES on Feb. 17 for "Small molecule compound serving as jak kinase inhibitor, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,780, issued on Feb. 17, was assigned to TECHNODERMA MEDICINES INC. (Sichuan, China).

"Small molecule compound serving as jak kinase inhibitor, and use thereof" was invented by Wenkui Ken Fang (Sichuan, China), Guanqun Li (Sichuan, China), Yuting Cai (Sichuan, China), Xiang Pan (Sichuan, China), Wenhao Zhu (Sichuan, China), Yang Wang (Sichuan, China) and Zengquan Wang (Sichuan, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a small molecule compound. The small molecule compound is a compound represented by the following formula (1), or a stereoisomer, geometric isomer, tautomer, hydrate, solvate, and pharmaceutica...